Overview
Beacon Biosignals applies machine learning to EEG data to deliver scalable neural biomarkers for clinical trials and neurology applications. Their Dreem headband and cloud analytics platform help pharma companies measure brain activity endpoints at scale.
More in Neurodiagnostics
Latest industry news
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-09-23 · Policy
Vagus Nerve Stimulation Enters the Sports Performance Arena With New Anxiety Support Device
2026-09-22 · Product
Aurenar Raises $5.7M to Accelerate Stroke Neuromodulation Device Development
2026-09-21 · Funding
UCANACT Raises €800,000 to Advance Brain-Computer Communication Technology
2026-09-20 · Funding
Company details
Category
🔬 Neurodiagnostics
Location
Boston, USA
Funding
Series B · $45M
Website
beacon.bioListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →